Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells
Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bo...
Gespeichert in:
Veröffentlicht in: | Experimental neurology 2025-03, Vol.385, p.115124, Article 115124 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | 115124 |
container_title | Experimental neurology |
container_volume | 385 |
creator | Zhang, Qian Zhang, Zhiqiang Xiu, Yihong Zou, Tianyu Quan, Yaping |
description | Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bone marrow mesenchymal stem cells (BMSCs), has a considerable therapeutic effect on brain injury in rats. Here, we speculate that SF also exerts cerebroprotective effects. In this study, we found that after SF intervention, thrombospondin 4 (TSP4) protein expression increased in oxygen glucose deprivation/restoration (OGD/R)–treated human brain microvascular endothelial cells (HBMECs). In addition, the transfection of sh-TPS4 reversed the inhibitory effects of SF on inflammatory infiltration, oxidative stress and apoptosis and promoted effects on cell migration and angiogenesis. BMSCs have strong proliferation ability and multi-directional differentiation potential and alleviate brain injury. We found that compared with wild-type BMSCs, the TSP4-modified BMSCs had a more considerable effect that alleviated OGD/R-induced cell injury. Furthermore, SF combined with TSP4-modified BMSCs promoted the repair of damaged OGD/R-treated HBMECs by activating the PI3K/AKT/mTOR pathway. In the rat middle cerebral artery occlusion (MCAO) model, the therapeutic effect of SF combined with BMSCs on brain injury in rats was better than that of SF alone, and the therapeutic effect of the TSP4-modified BMSCs was better than that of the wild-type BMSCs. In conclusion, our results showed that SF upregulated TSP4 expression and combined with BMSCs to promote repair of damaged OGD/R-treated HBMECs and improve ischaemic stroke in rats.
•Sodium ferulate improves ischemic stroke.•Sodium ferulate upregulates thrombospondin-4 expression.•SF combined with TSP4 modified BMSCs improves ischemic stroke. |
doi_str_mv | 10.1016/j.expneurol.2024.115124 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3148495044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0014488624004503</els_id><sourcerecordid>3148495044</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1623-b7055060486343e2a6ef2fc27bec9c81d197f176976d1d176cb16504817d325a3</originalsourceid><addsrcrecordid>eNqFUU1v1DAQtRCIbgt_AXzkksV2HDs5VhW0lSpxaDlbjjPpeknsYDuU_UX8TWa1pVdO_pj35s28R8hHzraccfV5v4XfS4A1xWkrmJBbzhsu5Cuy4axjlZA1e002jHFZybZVZ-Q85z1jrJNCvyVndac5suoN-XMfB7_OdIS0TrYAtaVAWPGWqc9uZ2H2juaS4g-g_YHOMHhbfHikZQd0XRI8Hnk-BhpH_Etx7mNeYhh8qCTFKRPkfCzbMFCHVR9goCWBLTOEQp982dE-BqCzTSk-oUKG4HaH2U6oCzN1ME35HXkz2inD--fzgnz_-uXh6qa6-3Z9e3V5VzmuRF31mjUNU0y2qpY1CKtgFKMTugfXuZYPvNMj16rTasCHVq7nqkE410MtGltfkE-nvkuKP1fIxcxoA05gA8Q1m5rLVnbIkAjVJ6hLMecEo1mSxyUOhjNzTMnszUtK5piSOaWEzA_PImuPhr7w_sWCgMsTAHDVXx6Syc6jK2h-AlfMEP1_Rf4CADir-w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3148495044</pqid></control><display><type>article</type><title>Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><creator>Zhang, Qian ; Zhang, Zhiqiang ; Xiu, Yihong ; Zou, Tianyu ; Quan, Yaping</creator><creatorcontrib>Zhang, Qian ; Zhang, Zhiqiang ; Xiu, Yihong ; Zou, Tianyu ; Quan, Yaping</creatorcontrib><description>Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bone marrow mesenchymal stem cells (BMSCs), has a considerable therapeutic effect on brain injury in rats. Here, we speculate that SF also exerts cerebroprotective effects. In this study, we found that after SF intervention, thrombospondin 4 (TSP4) protein expression increased in oxygen glucose deprivation/restoration (OGD/R)–treated human brain microvascular endothelial cells (HBMECs). In addition, the transfection of sh-TPS4 reversed the inhibitory effects of SF on inflammatory infiltration, oxidative stress and apoptosis and promoted effects on cell migration and angiogenesis. BMSCs have strong proliferation ability and multi-directional differentiation potential and alleviate brain injury. We found that compared with wild-type BMSCs, the TSP4-modified BMSCs had a more considerable effect that alleviated OGD/R-induced cell injury. Furthermore, SF combined with TSP4-modified BMSCs promoted the repair of damaged OGD/R-treated HBMECs by activating the PI3K/AKT/mTOR pathway. In the rat middle cerebral artery occlusion (MCAO) model, the therapeutic effect of SF combined with BMSCs on brain injury in rats was better than that of SF alone, and the therapeutic effect of the TSP4-modified BMSCs was better than that of the wild-type BMSCs. In conclusion, our results showed that SF upregulated TSP4 expression and combined with BMSCs to promote repair of damaged OGD/R-treated HBMECs and improve ischaemic stroke in rats.
•Sodium ferulate improves ischemic stroke.•Sodium ferulate upregulates thrombospondin-4 expression.•SF combined with TSP4 modified BMSCs improves ischemic stroke.</description><identifier>ISSN: 0014-4886</identifier><identifier>ISSN: 1090-2430</identifier><identifier>EISSN: 1090-2430</identifier><identifier>DOI: 10.1016/j.expneurol.2024.115124</identifier><identifier>PMID: 39710243</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>BMSCs ; HBMECs ; Ischaemic stroke ; Sodium ferulate ; Thrombospondin-4</subject><ispartof>Experimental neurology, 2025-03, Vol.385, p.115124, Article 115124</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1623-b7055060486343e2a6ef2fc27bec9c81d197f176976d1d176cb16504817d325a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.expneurol.2024.115124$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,778,782,3539,27907,27908,45978</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39710243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Zhang, Zhiqiang</creatorcontrib><creatorcontrib>Xiu, Yihong</creatorcontrib><creatorcontrib>Zou, Tianyu</creatorcontrib><creatorcontrib>Quan, Yaping</creatorcontrib><title>Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells</title><title>Experimental neurology</title><addtitle>Exp Neurol</addtitle><description>Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bone marrow mesenchymal stem cells (BMSCs), has a considerable therapeutic effect on brain injury in rats. Here, we speculate that SF also exerts cerebroprotective effects. In this study, we found that after SF intervention, thrombospondin 4 (TSP4) protein expression increased in oxygen glucose deprivation/restoration (OGD/R)–treated human brain microvascular endothelial cells (HBMECs). In addition, the transfection of sh-TPS4 reversed the inhibitory effects of SF on inflammatory infiltration, oxidative stress and apoptosis and promoted effects on cell migration and angiogenesis. BMSCs have strong proliferation ability and multi-directional differentiation potential and alleviate brain injury. We found that compared with wild-type BMSCs, the TSP4-modified BMSCs had a more considerable effect that alleviated OGD/R-induced cell injury. Furthermore, SF combined with TSP4-modified BMSCs promoted the repair of damaged OGD/R-treated HBMECs by activating the PI3K/AKT/mTOR pathway. In the rat middle cerebral artery occlusion (MCAO) model, the therapeutic effect of SF combined with BMSCs on brain injury in rats was better than that of SF alone, and the therapeutic effect of the TSP4-modified BMSCs was better than that of the wild-type BMSCs. In conclusion, our results showed that SF upregulated TSP4 expression and combined with BMSCs to promote repair of damaged OGD/R-treated HBMECs and improve ischaemic stroke in rats.
•Sodium ferulate improves ischemic stroke.•Sodium ferulate upregulates thrombospondin-4 expression.•SF combined with TSP4 modified BMSCs improves ischemic stroke.</description><subject>BMSCs</subject><subject>HBMECs</subject><subject>Ischaemic stroke</subject><subject>Sodium ferulate</subject><subject>Thrombospondin-4</subject><issn>0014-4886</issn><issn>1090-2430</issn><issn>1090-2430</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><recordid>eNqFUU1v1DAQtRCIbgt_AXzkksV2HDs5VhW0lSpxaDlbjjPpeknsYDuU_UX8TWa1pVdO_pj35s28R8hHzraccfV5v4XfS4A1xWkrmJBbzhsu5Cuy4axjlZA1e002jHFZybZVZ-Q85z1jrJNCvyVndac5suoN-XMfB7_OdIS0TrYAtaVAWPGWqc9uZ2H2juaS4g-g_YHOMHhbfHikZQd0XRI8Hnk-BhpH_Etx7mNeYhh8qCTFKRPkfCzbMFCHVR9goCWBLTOEQp982dE-BqCzTSk-oUKG4HaH2U6oCzN1ME35HXkz2inD--fzgnz_-uXh6qa6-3Z9e3V5VzmuRF31mjUNU0y2qpY1CKtgFKMTugfXuZYPvNMj16rTasCHVq7nqkE410MtGltfkE-nvkuKP1fIxcxoA05gA8Q1m5rLVnbIkAjVJ6hLMecEo1mSxyUOhjNzTMnszUtK5piSOaWEzA_PImuPhr7w_sWCgMsTAHDVXx6Syc6jK2h-AlfMEP1_Rf4CADir-w</recordid><startdate>202503</startdate><enddate>202503</enddate><creator>Zhang, Qian</creator><creator>Zhang, Zhiqiang</creator><creator>Xiu, Yihong</creator><creator>Zou, Tianyu</creator><creator>Quan, Yaping</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202503</creationdate><title>Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells</title><author>Zhang, Qian ; Zhang, Zhiqiang ; Xiu, Yihong ; Zou, Tianyu ; Quan, Yaping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1623-b7055060486343e2a6ef2fc27bec9c81d197f176976d1d176cb16504817d325a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>BMSCs</topic><topic>HBMECs</topic><topic>Ischaemic stroke</topic><topic>Sodium ferulate</topic><topic>Thrombospondin-4</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Qian</creatorcontrib><creatorcontrib>Zhang, Zhiqiang</creatorcontrib><creatorcontrib>Xiu, Yihong</creatorcontrib><creatorcontrib>Zou, Tianyu</creatorcontrib><creatorcontrib>Quan, Yaping</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Qian</au><au>Zhang, Zhiqiang</au><au>Xiu, Yihong</au><au>Zou, Tianyu</au><au>Quan, Yaping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells</atitle><jtitle>Experimental neurology</jtitle><addtitle>Exp Neurol</addtitle><date>2025-03</date><risdate>2025</risdate><volume>385</volume><spage>115124</spage><pages>115124-</pages><artnum>115124</artnum><issn>0014-4886</issn><issn>1090-2430</issn><eissn>1090-2430</eissn><abstract>Ischaemic stroke is one of the major diseases affecting human health, involving complex and diverse pathological mechanisms, including inflammatory response, oxidative stress and angiogenesis. Sodium ferulate (SF) exerts a protective effect on cerebral ischaemia/reperfusion and when combined with bone marrow mesenchymal stem cells (BMSCs), has a considerable therapeutic effect on brain injury in rats. Here, we speculate that SF also exerts cerebroprotective effects. In this study, we found that after SF intervention, thrombospondin 4 (TSP4) protein expression increased in oxygen glucose deprivation/restoration (OGD/R)–treated human brain microvascular endothelial cells (HBMECs). In addition, the transfection of sh-TPS4 reversed the inhibitory effects of SF on inflammatory infiltration, oxidative stress and apoptosis and promoted effects on cell migration and angiogenesis. BMSCs have strong proliferation ability and multi-directional differentiation potential and alleviate brain injury. We found that compared with wild-type BMSCs, the TSP4-modified BMSCs had a more considerable effect that alleviated OGD/R-induced cell injury. Furthermore, SF combined with TSP4-modified BMSCs promoted the repair of damaged OGD/R-treated HBMECs by activating the PI3K/AKT/mTOR pathway. In the rat middle cerebral artery occlusion (MCAO) model, the therapeutic effect of SF combined with BMSCs on brain injury in rats was better than that of SF alone, and the therapeutic effect of the TSP4-modified BMSCs was better than that of the wild-type BMSCs. In conclusion, our results showed that SF upregulated TSP4 expression and combined with BMSCs to promote repair of damaged OGD/R-treated HBMECs and improve ischaemic stroke in rats.
•Sodium ferulate improves ischemic stroke.•Sodium ferulate upregulates thrombospondin-4 expression.•SF combined with TSP4 modified BMSCs improves ischemic stroke.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39710243</pmid><doi>10.1016/j.expneurol.2024.115124</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-4886 |
ispartof | Experimental neurology, 2025-03, Vol.385, p.115124, Article 115124 |
issn | 0014-4886 1090-2430 1090-2430 |
language | eng |
recordid | cdi_proquest_miscellaneous_3148495044 |
source | Elsevier ScienceDirect Journals Complete - AutoHoldings |
subjects | BMSCs HBMECs Ischaemic stroke Sodium ferulate Thrombospondin-4 |
title | Sodium ferulate attenuates ischaemic stroke by mediating the upregulation of thrombospondin-4 expression and combined treatment with bone marrow mesenchymal stem cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A05%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sodium%20ferulate%20attenuates%20ischaemic%20stroke%20by%20mediating%20the%20upregulation%20of%20thrombospondin-4%20expression%20and%20combined%20treatment%20with%20bone%20marrow%20mesenchymal%20stem%20cells&rft.jtitle=Experimental%20neurology&rft.au=Zhang,%20Qian&rft.date=2025-03&rft.volume=385&rft.spage=115124&rft.pages=115124-&rft.artnum=115124&rft.issn=0014-4886&rft.eissn=1090-2430&rft_id=info:doi/10.1016/j.expneurol.2024.115124&rft_dat=%3Cproquest_cross%3E3148495044%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3148495044&rft_id=info:pmid/39710243&rft_els_id=S0014488624004503&rfr_iscdi=true |